Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Consulting agrmnt
Director departure
Appointed director
CC transcript
Notes underwriting agrmnt
Inv. presentation
|
|
Sarepta Therapeutics, Inc. (SRPT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/04/2023 |
3
| Arif Bilal (Chief Tech Ops Officer) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 06/06/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/06/2022 |
3
| Boor Kathryn Jean (Director) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 11/17/2021 |
3
| Mayo Stephen (Director) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 03/05/2021 |
3
| Brown Ryan Edward (SVP, General Counsel) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 12/14/2020 |
3
| Rodino-Klapac Louise (Chief Scientific Officer) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 12/14/2020 |
3
| Estepan Ian Michael (CFO) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 08/05/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/21/2020 |
3
| MARTIN JOHN C (Director) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 11/20/2019 |
3
| Ciambrone William (EVP) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 12/11/2018 |
3
| GRAY MARY ANN (Director) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 06/11/2018 |
3
| O'Neill Gilmore Neil (SVP & Chief Medical Officer) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 12/05/2017 |
3
| BONNEY MICHAEL W (Director) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 09/25/2017 |
3
| Basi Guriqbal S. (SVP, Chief Scientific Officer) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 06/28/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 04/05/2017 |
3
| Stehman-Breen Catherine (SVP, Chief Medical Officer) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 09/30/2016 |
3
| Ruff Shamim (SVP, Regulatory Affairs & Qual) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 09/30/2016 |
3
| Wood Joan (VP, Human Resources) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 09/30/2016 |
3
| Cumbo Alexander (VP, Head of Commercial) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 04/19/2013 |
3
| Aphale Jayant (SVP, Technical Operations) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 04/19/2013 |
3
| Martignetti Anthony (See Remarks) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 11/07/2012 |
3
| Howton David T (SVP, General Counsel) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 11/07/2012 |
3
| Mahatme Sandesh (Senior Vice President, CFO) has filed a Form 3 on Sarepta Therapeutics, Inc. |
| 09/06/2011 |
3
| JACOBSEN MICHAEL A (VP of Finance and PAO) has filed a Form 3 on AVI BIOPHARMA INC |
| 07/29/2011 |
3
| MILE MELINDA G (Controller and PAO) has filed a Form 3 on AVI BIOPHARMA INC |
| 06/20/2011 |
3
| Kaye Edward M. MD (Sr VP & Chief Medical Officer) has filed a Form 3 on AVI BIOPHARMA INC |
| 01/10/2011 |
3
| Toshav Bracha Ephrat (Sr VP & General Counsel) has filed a Form 3 on AVI BIOPHARMA INC |
| 08/25/2010 |
3
| JOHNSON GRAHAM (Sr VP Preclinical Dev & Rsrch) has filed a Form 3 on AVI BIOPHARMA INC |
| 06/08/2010 |
3
| Christopher Nishan Garabedian (Director) has filed a Form 3 on AVI BIOPHARMA INC |
| 06/08/2010 |
3
| Wigzell Hans Lennart Rudolf (Director) has filed a Form 3 on AVI BIOPHARMA INC |
| 04/22/2010 |
3
| CHASE ANTHONY R (Director) has filed a Form 3 on AVI BIOPHARMA INC |
| 03/26/2010 |
3
| HAYWOOD GEORGE WEAVER (May be deemed 10% group member) has filed a Form 3 on AVI BIOPHARMA INC |
| 03/26/2010 |
3
| Rockall Emerging Markets Master Fund Ltd (May be deemed 10% group member) has filed a Form 3 on AVI BIOPHARMA INC |
| 06/02/2009 |
3
| BLACK BEAR OFFSHORE MASTER FUND LP (10% Owner) has filed a Form 3 on AVI BIOPHARMA INC |
|
|
|